相似文献
1
Chapter 7: Idiopathic membranous nephropathy.第7章：特发性膜性肾病。
Kidney Int Suppl (2011). 2012 Jun;2(2):186-197. doi: 10.1038/kisup.2012.20.
2
Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy.在特发性膜性肾病中，Th2细胞因子增加并刺激B细胞产生IgG4。
Kidney Int. 2005 Jul;68(1):302-10. doi: 10.1111/j.1523-1755.2005.00415.x.
3
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
4
Rituximab In The Treatment Of Refractory Idiopathic Membranous Nephropathy In Pakistani Population.利妥昔单抗治疗巴基斯坦人群难治性特发性膜性肾病
J Ayub Med Coll Abbottabad. 2019 Apr-Jun;31(2):265-268.
5
Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis.特发性膜性肾病中2型免疫反应的优势。细胞质细胞因子分析。
Nephron. 2002 Jun;91(2):255-61. doi: 10.1159/000058401.
6
Clinicopathological features of idiopathic membranous nephropathy combined with IgA nephropathy: a retrospective analysis of 9 cases.特发性膜性肾病合并IgA肾病的临床病理特征：9例回顾性分析
Diagn Pathol. 2016 Sep 13;11(1):86. doi: 10.1186/s13000-016-0538-7.
7
8
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.特发性膜性肾病中的含血小板反应蛋白1型结构域7A
N Engl J Med. 2014 Dec 11;371(24):2277-2287. doi: 10.1056/NEJMoa1409354. Epub 2014 Nov 13.
9
Detection and clinical significance of glomerular M-type phospholipase A receptor in patients with idiopathic membranous nephropathy.特发性膜性肾病患者肾小球 M 型磷脂酶 A 受体的检测及临床意义。
Intern Med J. 2016 Nov;46(11):1318-1322. doi: 10.1111/imj.13233.
10
Association of podocyte autophagosome numbers with idiopathic membranous nephropathy and secondary membranous nephropathy.足细胞自噬体数量与特发性膜性肾病及继发性膜性肾病的关联。
Int Urol Nephrol. 2017 Jun;49(6):1025-1031. doi: 10.1007/s11255-017-1555-5. Epub 2017 Mar 11.
引用本文的文献
1
Synchronous papillary renal neoplasm with reverse polarity and membranous nephropathy: a rare case report.伴有反向极性的同步性乳头状肾肿瘤与膜性肾病：一例罕见病例报告
Front Oncol. 2025 May 16;15:1512036. doi: 10.3389/fonc.2025.1512036. eCollection 2025.
2
Effects of immunosuppressive therapy on renal prognosis in primary membranous nephropathy.免疫抑制疗法对原发性膜性肾病肾脏预后的影响。
BMC Nephrol. 2024 Oct 24;25(1):377. doi: 10.1186/s12882-024-03796-4.
3
Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial.麻黄附子细辛汤治疗原发性膜性肾病的疗效及安全性：一项多中心前瞻性试验。
Ren Fail. 2024 Dec;46(1):2320834. doi: 10.1080/0886022X.2024.2320834. Epub 2024 Mar 14.
4
Clinicopathological characteristics and outcomes of PLA2R related idiopathic membranous nephropathy in patients with seronegative PLA2R antibodies.血清阴性PLA2R抗体患者中PLA2R相关特发性膜性肾病的临床病理特征及预后
Ren Fail. 2024 Dec;46(1):2297015. doi: 10.1080/0886022X.2023.2297015. Epub 2024 Jan 26.
5
Membranous nephropathy.膜性肾病。
J Bras Nefrol. 2023 Apr-Jun;45(2):229-243. doi: 10.1590/2175-8239-JBN-2023-0046en.
6
The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy --protocol of a multicenter, randomized control trial (SQ-AUTUMN).三芪祛湿颗粒治疗特发性膜性肾病随机、双盲、安慰剂平行对照、多中心临床试验方案（SQ-AUTUMN）
BMC Complement Med Ther. 2023 Apr 27;23(1):134. doi: 10.1186/s12906-023-03950-9.
7
A preliminary nomogram model for predicting relapse of patients with primary membranous nephropathy.原发性膜性肾病患者复发的初步列线图模型。
Ren Fail. 2023 Dec;45(1):2199092. doi: 10.1080/0886022X.2023.2199092.
8
Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy.高胆固醇血症与肾小球磷脂酶 A2 受体沉积及血清抗磷脂酶 A2 受体抗体相关，并可预测特发性膜性肾病的蛋白尿转归。
Front Immunol. 2022 Jun 17;13:905930. doi: 10.3389/fimmu.2022.905930. eCollection 2022.
9
The Role of Anti-PLAR and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice.抗 PLAR 和抗 THSD7A 抗体在原发性膜性肾病发病机制和诊断中的作用：临床实践的最新知识综述。
Int J Environ Res Public Health. 2022 Apr 27;19(9):5301. doi: 10.3390/ijerph19095301.
10
Efficacy and safety of tacrolimus monotherapy versus tacrolimus-corticosteroid combination therapy for idiopathic membranous nephropathy: A meta-analysis.他克莫司单药治疗与他克莫司-皮质类固醇联合治疗特发性膜性肾病的疗效和安全性：一项荟萃分析。
Medicine (Baltimore). 2021 Dec 23;100(51):e28225. doi: 10.1097/MD.0000000000028225.
本文引用的文献
1
Clinical trial of focal segmental glomerulosclerosis in children and young adults.儿童及青年局灶节段性肾小球硬化症的临床试验。
Kidney Int. 2011 Oct;80(8):868-78. doi: 10.1038/ki.2011.195. Epub 2011 Jul 6.
2
Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.特发性膜性肾病和肾病综合征：基于证据的治疗时代的结局。
Nephrol Dial Transplant. 2012 Jan;27(1):235-42. doi: 10.1093/ndt/gfr220. Epub 2011 May 10.
3
Rituximab therapy in idiopathic membranous nephropathy: a 2-year study.利妥昔单抗治疗特发性膜性肾病：一项为期 2 年的研究。
Clin J Am Soc Nephrol. 2010 Dec;5(12):2188-98. doi: 10.2215/CJN.05080610. Epub 2010 Aug 12.
4
Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.他克莫司联合皮质类固醇治疗特发性膜性肾病肾病综合征：一项多中心随机对照试验。
Am J Med Sci. 2010 Mar;339(3):233-8. doi: 10.1097/MAJ.0b013e3181ca3a7d.
5
Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.血管紧张素转换酶抑制剂赖诺普利与血管紧张素II受体拮抗剂氯沙坦对特发性膜性肾病合并肾病综合征患者影响的比较
Scand J Urol Nephrol. 2010 Sep;44(4):251-6. doi: 10.3109/00365591003667351.
6
Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.特发性膜性肾病肾病综合征自发缓解。
J Am Soc Nephrol. 2010 Apr;21(4):697-704. doi: 10.1681/ASN.2009080861. Epub 2010 Jan 28.
7
Membranous nephropathy in children: clinical presentation and therapeutic approach.儿童膜性肾病：临床表现与治疗方法。
Pediatr Nephrol. 2010 Aug;25(8):1419-28. doi: 10.1007/s00467-009-1324-5. Epub 2009 Nov 12.
8
Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.特发性膜性肾病中免疫抑制治疗的早期与晚期开始：一项随机对照试验。
Nephrol Dial Transplant. 2010 Jan;25(1):129-36. doi: 10.1093/ndt/gfp390. Epub 2009 Aug 8.
9
Controversies in the treatment of idiopathic membranous nephropathy.特发性膜性肾病治疗中的争议
Nat Rev Nephrol. 2009 Aug;5(8):469-79. doi: 10.1038/nrneph.2009.101. Epub 2009 Jul 7.
10
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.M型磷脂酶A2受体作为特发性膜性肾病的靶抗原
N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
Zotero 插件